Recombinant mouse Interferon gamma protein (Active)
- Bioactive
- What is this?
5
(1 Review)
|
(13 Publications)
Recombinant mouse Interferon gamma protein (Active) is a Mouse Full Length protein, in the 23 to 155 aa range, expressed in Escherichia coli, with >98%, < 1 EU/µg endotoxin level, suitable for SDS-PAGE, FuncS, HPLC.
View Alternative Names
Interferon gamma, IFN-gamma, Ifng
Reactivity data
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This cytokine is significant in promoting macrophage activation enhancing the antigen presentation process and boosting the antimicrobial activity of phagocytes. IFN-γ is not part of a larger protein complex but works as a homodimer in signal transduction. Its production heightens the Th1 immune response by stimulating the differentiation of naïve T cells into Th1 cells which is essential for effective cellular immunity.
Pathways
IFN-γ is integrally involved in the JAK-STAT signaling pathway alongside another critical cytokine Interleukin-12. This pathway further amplifies the immune response by regulating the expression of genes associated with cellular defense mechanisms. IFN-γ also interacts with the NF-kB pathway influencing inflammation and the activation of further immune responses. These interactions show a network of cooperativity with proteins like STAT1 and NF-kB essential for executing its biological roles.
Specifications
Form
Lyophilized
Additional notes
>= HPLC analyses.Sterile filtered.
General info
Function
Type II interferon produced by immune cells such as T-cells and NK cells that plays crucial roles in antimicrobial, antiviral, and antitumor responses by activating effector immune cells and enhancing antigen presentation (PubMed : 11585387, PubMed : 8456301). Primarily signals through the JAK-STAT pathway after interaction with its receptor IFNGR1 to affect gene regulation. Upon IFNG binding, IFNGR1 intracellular domain opens out to allow association of downstream signaling components JAK2, JAK1 and STAT1, leading to STAT1 activation, nuclear translocation and transcription of IFNG-regulated genes. Many of the induced genes are transcription factors such as IRF1 that are able to further drive regulation of a next wave of transcription. Plays a role in class I antigen presentation pathway by inducing a replacement of catalytic proteasome subunits with immunoproteasome subunits. In turn, increases the quantity, quality, and repertoire of peptides for class I MHC loading. Increases the efficiency of peptide generation also by inducing the expression of activator PA28 that associates with the proteasome and alters its proteolytic cleavage preference. Up-regulates as well MHC II complexes on the cell surface by promoting expression of several key molecules such as cathepsins B/CTSB, H/CTSH, and L/CTSL (By similarity). Participates in the regulation of hematopoietic stem cells during development and under homeostatic conditions by affecting their development, quiescence, and differentiation (PubMed : 20535209, PubMed : 25078851).
Sequence similarities
Belongs to the type II (or gamma) interferon family.
Target data
Publications (13)
Recent publications for all applications. Explore the full list and refine your search
Journal of cachexia, sarcopenia and muscle 16:e13776 PubMed40183240
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy. Oncology 32:200783 PubMed38595983
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cancer immunology research 12:575-591 PubMed38588410
2024
Applications
Unspecified application
Species
Unspecified reactive species
Nature 619:632-639 PubMed37344599
2023
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 13:6539 PubMed36344500
2022
Applications
Unspecified application
Species
Unspecified reactive species
Clinical cancer research : an official journal of the American Association for Cancer Research 28:4551-4564 PubMed35920742
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cancer cell 39:54-67.e9 PubMed33385331
2021
Applications
Unspecified application
Species
Unspecified reactive species
Journal for immunotherapy of cancer 8: PubMed32581055
2020
Applications
Unspecified application
Species
Unspecified reactive species
Molecular therapy : the journal of the American So 28:2007-2022 PubMed32531238
2020
Applications
Unspecified application
Species
Unspecified reactive species
The Journal of biological chemistry 295:8036-8047 PubMed32354743
2020
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com